A nurse is planning to administer a tuberculin skin test to a client who has had an exposure to tuberculosis. Which of the following actions should the nurse plan to take?
Select an injection site that is free of scar tissue.
Massage the site following the injection.
Hold the needle at a 30 angle during injection
Inject 0.3 to 0.5 mL of the solution.
The Correct Answer is A
A. When administering a TST, the nurse should select an injection site that is free of scar tissue and areas with excessive hair, veins, or visible lesions. The preferred site for TST administration is the volar aspect of the forearm, approximately 2-4 inches below the elbow.
B. After administering the TST, the nurse should not massage or manipulate the injection site. Massaging the site can cause irritation or spread the solution, leading to inaccurate results.
C. he TST is administered intradermally, typically with a 27-gauge needle. The needle should be inserted with the bevel facing upward at a 5-15-degree angle.
D. The standard dose of tuberculin solution (e.g., purified protein derivative, PPD) for a TST is 0.1 mL containing 5 tuberculin units (TU).
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. Sore throat is a common side effect of carbamazepine. Carbamazepine causes agranulocytosis whose earliest sign is a sore throat.
B. Gingivitis is not a side effect associated with carbamazepine.
C. Urge incontinence, or the sudden, uncontrollable urge to urinate, is not a common adverse effect of carbamazepine.
D. Increased salivation is not a typical adverse effect of carbamazepine. While dry mouth is a possible side effect, increased salivation would be unusual.
Correct Answer is D
Explanation
D. The expected therapeutic effect of montelukast is the reduction of bronchial inflammation. By blocking leukotriene receptors, montelukast helps to prevent the constriction of airway muscles, decrease mucus secretion, and reduce inflammation in the airways. This can lead to improved asthma control and symptom management.
A. Montelukast is not indicated for the treatment of gastric acid-related conditions such as gastroesophageal reflux disease (GERD) or peptic ulcers.
B. Montelukast is not typically associated with peripheral vasodilation. Its primary mechanism of action involves blocking the action of leukotrienes, which are inflammatory mediators involved in allergic and asthmatic reactions.
C. Montelukast does not affect white blood cell (WBC) count.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.